TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 0 | 0 | 10 | -38 | -43 | -53 | -31 |
| P | %wins | 100 | 100 | 100 | 0 | 0 | 0 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/24/23 16:40 | 7/20/23 | TSBX | Turnstone Biologics Corp. | DE | Health | BioPrd | Biological Products, (No Diag | Gupta Rishi | CA | DT | P.d | 5,000 | 12.00 | 0 | 417 | 16 | 3,099 | I | |||||||||||||||
5/19/23 16:12 | 5/17/23 | ELVN | Enliven Therapeutics, Inc. | Health | Drug | Pharmaceutical Preparations | Gupta Rishi | CO | DT | M.d | 9 | 4.28 | 0 | 2 | 0 | 8,951 | I | ||||||||||||||||
5/15/23 18:06 | 5/11/23 | VRNA | Verona Pharma Plc | X0 | Health | Drug | Pharmaceutical Preparations | Gupta Rishi | X0 | D | S.m | -9,938 | 20.58 | 0 | -483 | -11 | 3,778 | I | |||||||||||||||
12/27/22 17:32 | 12/22/22 | VRNA | Verona Pharma Plc | X0 | Health | Drug | Pharmaceutical Preparations | Gupta Rishi | X0 | D | S.m | -136,001 | 22.15 | 0 | -6,140 | -15 | 34,086 | I | |||||||||||||||
10/29/15 18:14 | 10/27/15 | DMTX | Dimension Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gupta Rishi | MA | DT | P.d | 2,600 | 13.00 | 6 | 200 | 4 | 5,398 | I | 1 | 0 | 0 | 10 | -38 | -43 | -53 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |